Literature DB >> 8400325

Quantitative immunohistochemical determination of cathepsin-D and its relation with other variables.

S Veneroni1, M G Daidone, G Di Fronzo, V Cappelletti, D Amadori, A Riccobon, A Paradiso, M Correale, R Silvestrini.   

Abstract

The expression of cathepsin D was evaluated by immunohistochemistry on histologic sections from formalin-fixed samples in a series of 436 primary breast cancers. The fraction of cathepsin D-positive tumor cells was not related to tumor size or hormone receptor status, and only weakly related to proliferative activity, evaluated as the 3H-thymidine labeling index. Conversely, a higher fraction of positive cells was observed in node-positive than in node-negative tumors (p = 0.05). A matched comparison between immunohistochemical and immunoradiometric results on individual tumors was carried out on 100 cases and showed a significant association but with a correlation coefficient of 0.46. The agreement of results from the two assays was higher in ER- than in ER+ tumors, which sometimes showed an immunostaining limited to macrophages and normal epithelial cells. In situ evaluation has the main advantage of being specifically applicable to detection in tumor cells and allows the simultaneous determination of different biologic aspects for a more complete understanding of breast cancer biology.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8400325     DOI: 10.1007/bf00682695

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  20 in total

1.  Cathepsin D in breast cancer: a tissue marker associated with metastasis.

Authors:  H Rochefort
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Cathepsin D: an independent prognostic factor for metastasis of breast cancer.

Authors:  F Spyratos; T Maudelonde; J P Brouillet; M Brunet; A Defrenne; C Andrieu; K Hacene; A Desplaces; J Rouëssé; H Rochefort
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

4.  Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein.

Authors:  F Vignon; F Capony; M Chambon; G Freiss; M Garcia; H Rochefort
Journal:  Endocrinology       Date:  1986-04       Impact factor: 4.736

5.  A secreted glycoprotein induced by estrogen in human breast cancer cell lines.

Authors:  B Westley; H Rochefort
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

Review 6.  Cathepsin D in breast cancer.

Authors:  H Rochefort
Journal:  Breast Cancer Res Treat       Date:  1990-07       Impact factor: 4.872

7.  Cathepsin D and prognosis in breast cancer.

Authors:  A K Tandon; G M Clark; G C Chamness; J M Chirgwin; W L McGuire
Journal:  N Engl J Med       Date:  1990-02-01       Impact factor: 91.245

8.  Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays.

Authors:  T E Kute; Z M Shao; N K Sugg; R T Long; G B Russell; L D Case
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

9.  Prognostic relevance of cathepsin D versus oestrogen receptors in node negative breast cancers.

Authors:  G Granata; D Coradini; V Cappelletti; G Di Fronzo
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

10.  A double-labeling assay for simultaneous estimation and characterization of estrogen and progesterone receptors using radioiodinated estradiol and tritiated Org 2058.

Authors:  E Ronchi; G Granata; M Brivio; D Coradini; P Miodini; G Di Fronzo
Journal:  Tumori       Date:  1986-06-30
View more
  5 in total

1.  Cathepsin D detected by automated and quantitative immunohistochemistry in breast carcinomas: correlation with overall and disease free survival.

Authors:  C Charpin; S Garcia; C Bouvier; F Martini; M Lavaut; C Allasia; P Bonnier; L Andrac
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

2.  Immunohistochemical and clinical evaluation of cathepsin expression in soft tissue sarcomas.

Authors:  P Würl; H Taubert; A Meye; T Dansranjavin; E Weber; D Günther; D Berger; H Schmidt; H Dralle; F W Rath
Journal:  Virchows Arch       Date:  1997-03       Impact factor: 4.064

3.  Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods.

Authors:  U J Göhring; A Scharl; U Thelen; A Ahr; G Crombach; B R Titius
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

4.  Proliferation Markers and EGF in ACTH-Secreting Adenomas and Carcinomas of the Pituitary.

Authors:  Dorothee Lubke; Wolfgang Saeger; Dieter K. Ludecke
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

5.  Cathepsin D serum and urine concentration in superficial and invasive transitional bladder cancer as determined by surface plasmon resonance imaging.

Authors:  Ewa Gorodkiewicz; Tomasz Guszcz; Wieslawa Roszkowska-Jakimiec; Robert Kozłowski
Journal:  Oncol Lett       Date:  2014-06-12       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.